The future of anti-cancer histology lies in integrating advanced technologies such as next-generation sequencing and single-cell analysis. These technologies can provide in-depth information about the genetic and molecular landscape of tumors, aiding in personalized medicine. Additionally, the use of artificial intelligence in histological analysis promises to enhance diagnostic accuracy and treatment monitoring.
